These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25927528)

  • 1. Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease.
    Kuo B; Bhasin M; Jacquart J; Scult MA; Slipp L; Riklin EI; Lepoutre V; Comosa N; Norton BA; Dassatti A; Rosenblum J; Thurler AH; Surjanhata BC; Hasheminejad NN; Kagan L; Slawsby E; Rao SR; Macklin EA; Fricchione GL; Benson H; Libermann TA; Korzenik J; Denninger JW
    PLoS One; 2015; 10(4):e0123861. PubMed ID: 25927528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
    Edebol-Carlman H; Schrooten M; Ljótsson B; Boersma K; Linton S; Brummer RJ
    Scand J Pain; 2018 Jan; 18(1):81-91. PubMed ID: 29794287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does symptom activity explain psychological differences in patients with irritable bowel syndrome and inflammatory bowel disease? Results from a multi-center cross-sectional study.
    Berens S; Schaefert R; Baumeister D; Gauss A; Eich W; Tesarz J
    J Psychosom Res; 2019 Nov; 126():109836. PubMed ID: 31627144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome.
    Guadagnoli L; Mutlu EA; Doerfler B; Ibrahim A; Brenner D; Taft TH
    Qual Life Res; 2019 Aug; 28(8):2195-2205. PubMed ID: 30900206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life.
    Pace F; Molteni P; Bollani S; Sarzi-Puttini P; Stockbrügger R; Bianchi Porro G; Drossman DA
    Scand J Gastroenterol; 2003 Oct; 38(10):1031-8. PubMed ID: 14621276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.
    Jones MP; Wessinger S; Crowell MD
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):474-81. PubMed ID: 16616353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
    Gracie DJ; Hamlin JP; Ford AC
    Am J Gastroenterol; 2018 May; 113(5):702-712. PubMed ID: 29453384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.
    Hunt M; Miguez S; Dukas B; Onwude O; White S
    JMIR Mhealth Uhealth; 2021 May; 9(5):e26152. PubMed ID: 33872182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome.
    Piacentino D; Cesarini M; Badiali D; Pallotta N; Biondi M; Corazziari ES
    Riv Psichiatr; 2019; 54(2):75-83. PubMed ID: 30985832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease.
    Berrill JW; Gallacher J; Hood K; Green JT; Matthews SB; Campbell AK; Smith A
    Neurogastroenterol Motil; 2013 Nov; 25(11):918-e704. PubMed ID: 23981191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-up.
    Barberio B; Fairbrass KM; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2024 Feb; 36(2):e14713. PubMed ID: 37994228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.
    Maagaard L; Ankersen DV; Végh Z; Burisch J; Jensen L; Pedersen N; Munkholm P
    World J Gastroenterol; 2016 Apr; 22(15):4009-19. PubMed ID: 27099444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the health-related quality of life, affective status, and personality between irritable bowel syndrome and inflammatory bowel disease patients.
    Tkalcić M; Hauser G; Stimac D
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):862-7. PubMed ID: 19701092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of gastroenterologists and nurses regarding irritable bowel syndrome and inflammatory bowel disease.
    Dickman R; Segev M; Levi S; Reicher-Atir R; Steinmetz A; Horev N; Niv Y
    Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):813-7. PubMed ID: 21701390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.
    Berrill JW; Green JT; Hood K; Campbell AK
    Aliment Pharmacol Ther; 2013 Jul; 38(1):44-51. PubMed ID: 23668698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of gastroenterologists and patients regarding irritable bowel syndrome and inflammatory bowel disease.
    Levy S; Segev M; Reicher-Atir R; Steinmetz A; Horev N; Niv Y; Dickman R
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):40-6. PubMed ID: 24025978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease.
    Trieschmann K; Chang L; Park S; Naliboff B; Joshi S; Labus JS; Sauk JS; Limketkai BN; Mayer EA
    Neurogastroenterol Motil; 2022 Sep; 34(9):e14384. PubMed ID: 35478469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stigmatization toward irritable bowel syndrome and inflammatory bowel disease in an online cohort.
    Taft TH; Bedell A; Naftaly J; Keefer L
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27501483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.